US-based Technology Company Commences Sales of Its New Mental Health Treatment Device
Revolutionary Advancement in Mental Health Treatment: Nexalin Technology's Gen-2 Neurostimulation Device Reaches Oman.
In a significant development for mental health treatment, US-based Nexalin Technology, Inc., a leading innovator in neurostimulation technology, has commenced sales of its Generation-2 (Gen-2) Neurostimulation Device to a new mental health center in Oman. $Nexalin Technology(NXL.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
